These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1582969)

  • 1. Perspectives on the origins of multiple myeloma and plasmacytomas in mice.
    Potter M
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):211-23. PubMed ID: 1582969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
    Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice.
    Coleman AE; Ried T; Janz S
    Genes Chromosomes Cancer; 2000 Sep; 29(1):70-4. PubMed ID: 10918396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous plasmacytomas in myeloma. Relationship to tumor cell burden.
    Alberts DS; Lynch P
    Arch Dermatol; 1978 Dec; 114(12):1784-7. PubMed ID: 736585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
    Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of adjuvant-induced plasmacytomas of mice in relation to the pathogenesis of human multiple myeloma.
    Azar HA
    Ann Allergy; 1968 Jun; 26(6):293-8. PubMed ID: 4172770
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
    Potter M; Wiener F
    Carcinogenesis; 1992 Oct; 13(10):1681-97. PubMed ID: 1423827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 deletion may drive the clinical evolution and treatment response in multiple myeloma.
    López-Anglada L; Gutiérrez NC; García JL; Mateos MV; Flores T; San Miguel JF
    Eur J Haematol; 2010 Apr; 84(4):359-61. PubMed ID: 20002730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse plasmacytoma: an experimental model of human multiple myeloma.
    Gadó K; Silva S; Pálóczi K; Domján G; Falus A
    Haematologica; 2001 Mar; 86(3):227-36. PubMed ID: 11255268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S
    Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS; Han SS; Park SS; McNeil N; Janz S
    J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
    Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.
    Wavre A; Baur AS; Betz M; Mühlematter D; Jotterand M; Zaman K; Ketterer N
    Neuro Oncol; 2007 Jul; 9(3):370-2. PubMed ID: 17522337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental plasmacytomas in relation to human multiple myeloma.
    Azar HA
    Ann Clin Lab Sci; 1974; 4(3):157-63. PubMed ID: 4825619
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.